biopharma

Despite remarkable scientific progress in recent decades, current funding models for projects in early-stage drug development and climate change have failed. These projects tend to be expensive, risky, and lengthy. Andrew Lo and his colleagues at MIT suggest that crowdfunding and financial engineering can provide the solution to this funding problem.